Molecular biology of Bax and Bak activation and action

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 4, 2011, Pages 521-531

  Westphal, Dana ^a   Dewson, Grant ^a   Czabotar, Peter E ^a   Kluck, Ruth M ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Apoptosis; Bak; Bax; Conformation change; Mitochondrial permeability; Mitochondrion; Oligomerization

Indexed keywords

PROTEIN BAK; PROTEIN BAX;

CONFORMATIONAL TRANSITION; MITOCHONDRIAL PERMEABILITY; MITOCHONDRION; MOLECULAR BIOLOGY; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN TRANSPORT; REVIEW;

ANIMALS; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; HUMANS; MITOCHONDRIA; MOLECULAR BIOLOGY;

EUKARYOTA;

EID: 79952709680     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2010.12.019     Document Type: Review

References (111)

1. Jost P.J., Grabow S., Gray D., McKenzie M.D., Nachbur U., Huang D.C., Bouillet P., Thomas H.E., Borner C., Silke J., Strasser A., Kaufmann T. XIAP discriminates between type I and type II FAS-induced apoptosis. Nature 2009, 460:1035-1039.
2. Scaffidi C., Fulda S., Srinivasan A., Friesen C., Li F., Tomaselli K.J., Debatin K.-M., Krammer P.H., Peter M.E. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 1998, 17:1675-1687.
3. Willis S.N., Adams J.M. Life in the balance: how BH3-only proteins induce apoptosis. Curr. Opin. Cell Biol. 2005, 17:617-625.
4. Kvansakul M., Yang H., Fairlie W.D., Czabotar P.E., Fischer S.F., Perugini M.A., Huang D.C., Colman P.M. Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands. Cell Death Differ. 2008, 15:1564-1571.
5. Zha H., Aime-Sempe C., Sato T., Reed J.C. Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2. J. Biol. Chem. 1996, 271:7440-7444.
6. Giam M., Huang D.C., Bouillet P. BH3-only proteins and their roles in programmed cell death. Oncogene 2008, 27(Suppl 1):S128-S136.
7. Lomonosova E., Chinnadurai G. BH3-only proteins in apoptosis and beyond: an overview. Oncogene 2008, 27(Suppl 1):S2-S19.
8. Lindsten T., Ross A.J., King A., Zong W., Rathmell J.C., Shiels H.A., Ulrich E., Waymire K.G., Mahar P., Frauwirth K., Chen Y., Wei M., Eng V.M., Adelman D.M., Simon M.C., Ma A., Golden J.A., Evan G., Korsmeyer S.J., MacGregor G.R., Thompson C.B. The combined functions of proapoptotic Bcl-2 family members Bak and Bax are essential for normal development of multiple tissues. Mol. Cell 2000, 6:1389-1399.
9. Wei M.C., Zong W.X., Cheng E.H., Lindsten T., Panoutsakopoulou V., Ross A.J., Roth K.A., MacGregor G.R., Thompson C.B., Korsmeyer S.J. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001, 292:727-730.
10. L-Bak peptide complex: recognition between regulators of apoptosis. Science 1997, 275:983-986.
11. L/Bad peptide complex formation from structure, mutagenesis, and biophysical studies. Protein Sci. 2000, 9:2528-2534.
12. Czabotar P.E., Lee E.F., van Delft M.F., Day C.L., Smith B.J., Huang D.C.S., Fairlie W.D., Hinds M.G., Colman P.M. Structural insights into the degradation of Mcl-1 induced by BH3 domains. PNAS 2007, 104:6217-6222.
13. Chen L., Willis S.N., Wei A., Smith B.J., Fletcher J.I., Hinds M.G., Colman P.M., Day C.L., Adams J.M., Huang D.C. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol. Cell 2005, 17:393-403.
14. Kuwana T., Bouchier-Hayes L., Chipuk J.E., Bonzon C., Sullivan B.A., Green D.R., Newmeyer D.D. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol. Cell 2005, 17:525-535.
15. L/Bim fragment complex: implications for Bim function. Immunity 2003, 19:341-352.
16. Schinzel A., Kaufmann T., Borner C. Bcl-2 family members: integrators of survival and death signals in physiology and pathology [corrected]. Biochim. Biophys. Acta 2004, 1644:95-105.
17. Suzuki M., Youle R.J., Tjandra N. Structure of Bax: coregulation of dimer formation and intracellular localization. Cell 2000, 103:645-654.
18. Dewson G., Kluck R.M. Mechanisms by which Bak and Bax permeabilise mitochondria during apoptosis. J. Cell Sci. 2009, 122:2801-2808.
19. Cartron P.F., Gallenne T., Bougras G., Gautier F., Manero F., Vusio P., Meflah K., Vallette F.M., Juin P. The first alpha helix of Bax plays a necessary role in its ligand-induced activation by the BH3-only proteins Bid and PUMA. Mol. Cell 2004, 16:807-818.
20. Gavathiotis E., Suzuki M., Davis M.L., Pitter K., Bird G.H., Katz S.G., Tu H.C., Kim H., Cheng E.H., Tjandra N., Walensky L.D. BAX activation is initiated at a novel interaction site. Nature 2008, 455:1076-1081.
21. Chipuk J.E., Green D.R. How do BCL-2 proteins induce mitochondrial outer membrane permeabilization?. Trends Cell Biol. 2008, 18:157-164.
22. Leber B., Lin J., Andrews D.W. Still embedded together binding to membranes regulates Bcl-2 protein interactions. Oncogene 2010.
23. Czabotar P.E., Lessene G. Bcl-2 family proteins as therapeutic targets. Curr. Pharm. Des. 2010, 16:3132-3148.
24. Lessene G., Czabotar P.E., Colman P.M. BCL-2 family antagonists for cancer therapy. Nat. Rev. Drug Discov. 2008, 7:989-1000.
25. Griffiths G.J., Dubrez L., Morgan C.P., Jones N.A., Whitehouse J., Corfe B.M., Dive C., Hickman J.A. Cell damage-induced conformational changes of the pro-apoptotic protein Bak in vivo precede the onset of apoptosis. J. Cell Biol. 1999, 144:903-914.
26. Hsu Y.T., Wolter K.G., Youle R.J. Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis. Proc. Natl Acad. Sci. USA 1997, 94:3668-3672.
27. Wolter K.G., Hsu Y.T., Smith C.L., Nechushtan A., Xi X.G., Youle R.J. Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol. 1997, 139:1281-1292.
28. Scorrano L., Oakes S.A., Opferman J.T., Cheng E.H., Sorcinelli M.D., Pozzan T., Korsmeyer S.J. BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis. Science 2003, 300:135-139.
29. Zong W.X., Li C., Hatzuvassiliou G., Lindsten T., Yu Q.C., Yuan J., Thompson C.B. Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis. J. Cell Biol. 2003, 162:59-69.
30. Kim H., Tu H.C., Ren D., Takeuchi O., Jeffers J.R., Zambetti G.P., Hsieh J.J., Cheng E.H. Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis. Mol. Cell 2009, 36:487-499.
31. Moldoveanu T., Liu Q., Tocilj A., Watson M.H., Shore G., Gehring K. The X-ray structure of a BAK homodimer reveals an inhibitory zinc binding site. Mol. Cell 2006, 24:677-688.
32. Wang H., Takemoto C., Akasaka R., Uchikubo-Kamo T., Kishishita S., Murayama K., Terada T., Chen L., Liu Z.J., Wang B.C., Sugano S., Tanaka A., Inoue M., Kigawa T., Shirouzu M., Yokoyama S. Novel dimerization mode of the human Bcl-2 family protein Bak, a mitochondrial apoptosis regulator. J. Struct. Biol. 2009, 166:32-37.
33. Hinds M.G., Day C.L. Regulation of apoptosis: uncovering the binding determinants. Curr. Opin. Struct. Biol. 2005, 15:690-699.
34. Lindsay J., Esposti M.D., Gilmore A.P. Bcl-2 proteins and mitochondria-Specificity in membrane targeting for death. Biochim Biophys Acta 2010.
35. Tan C., Dlugosz P.J., Peng J., Zhang Z., Lapolla S.M., Plafker S.M., Andrews D.W., Lin J. Auto-activation of the apoptosis protein Bax increases mitochondrial membrane permeability and is inhibited by Bcl-2. J. Biol. Chem. 2006, 281:14764-14775.
36. Letai A., Bassik M.C., Walensky L.D., Sorcinelli M.D., Weiler S., Korsmeyer S.J. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2002, 2:183-192.
37. Certo M., Moore Vdel G., Nishino M., Wei G., Korsmeyer S., Armstrong S.A., Letai A. Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Cancer Cell 2006, 9:351-365.
38. Khaled A.R., Kim K., Hofmeister R., Muegge K., Durum S.K. Withdrawal of IL-7 induces bax translocation from cytosol to mitochondria through a rise in intracellular pH. Proc. Natl Acad. Sci. USA 1999, 96:14476-14481.
39. Kim B.J., Ryu S.W., Song B.J. JNK- and p38 kinase-mediated phosphorylation of Bax leads to its activation and mitochondrial translocation and to apoptosis of human hepatoma HepG2 cells. J. Biol. Chem. 2006, 281:21256-21265.
40. Linseman D.A., Butts B.D., Precht T.A., Phelps R.A., Le S.S., Laessig T.A., Bouchard R.J., Florez-McClure M.L., Heidenreich K.A. Glycogen synthase kinase-3beta phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis. J. Neurosci. 2004, 24:9993-10002.
41. Nie C., Tian C., Zhao L., Petit P.X., Mehrpour M., Chen Q. Cysteine 62 of Bax is critical for its conformational activation and its proapoptotic activity in response to H2O2-induced apoptosis. J. Biol. Chem. 2008, 283:15359-15369.
42. Pagliari L.J., Kuwana T., Bonzon C., Newmeyer D.D., Tu S., Beere H.M., Green D.R. The multidomain proapoptotic molecules Bax and Bak are directly activated by heat. Proc. Natl Acad. Sci. USA 2005, 102:17975-17980.
43. Wood D.E., Newcomb E.W. Cleavage of Bax enhances its cell death function. Exp. Cell Res. 2000, 256:375-382.
44. Nechushtan A., Smith C.L., Hsu Y.T., Youle R.J. Conformation of the Bax C-terminus regulates subcellular location and cell death. EMBO J. 1999, 18:2330-2341.
45. Schinzel A., Kaufmann T., Schuler M., Martinalbo J., Grubb D., Borner C. Conformational control of Bax localization and apoptotic activity by Pro168. J. Cell Biol. 2004, 164:1021-1032.
46. Valentijn A.J., Upton J.P., Gilmore A.P. Analysis of endogenous Bax complexes during apoptosis using blue native PAGE: implications for Bax activation and oligomerization. Biochem. J. 2008, 412:347-357.
47. Cartron P.F., Priault M., Oliver L., Meflah K., Manon S., Vallette F.M. The N-terminal end of Bax contains a mitochondrial-targeting signal. J. Biol. Chem. 2003, 278:11633-11641.
48. Brock S.E., Li C., Wattenberg B.W. The Bax carboxy-terminal hydrophobic helix does not determine organelle-specific targeting but is essential for maintaining Bax in an inactive state and for stable mitochondrial membrane insertion. Apoptosis 2010, 15:14-27.
49. Tremblais K., Oliver L., Juin P., Le Cabellec T.M., Meflah K., Vallette F.M. The C-terminus of bax is not a membrane addressing/anchoring signal. Biochem. Biophys. Res. Commun. 1999, 260:582-591.
50. Cartron P.F., Arokium H., Oliver L., Meflah K., Manon S., Vallette F.M. Distinct domains control the addressing and the insertion of Bax into mitochondria. J. Biol. Chem. 2005, 280:10587-10598.
51. Setoguchi K., Otera H., Mihara K. Cytosolic factor- and TOM-independent import of C-tail-anchored mitochondrial outer membrane proteins. EMBO J. 2006, 25:5635-5647.
52. Dewson G., Kratina T., Czabotar P., Day C.L., Adams J.M., Kluck R.M. Bak activation for apoptosis involves oligomerization of dimers via their alpha6 helices. Mol. Cell 2009, 36:696-703.
53. Goping I.S., Gross A., Lavoie J.N., Nguyen M., Jemmerson R., Roth K., Korsmeyer S.J., Shore G.C. Regulated targeting of BAX to mitochondria. J. Cell Biol. 1998, 143:207-215.
54. Cartron P.F., Oliver L., Martin S., Moreau C., LeCabellec M.T., Jezequel P., Meflah K., Vallette F.M. The expression of a new variant of the pro-apoptotic molecule Bax, Baxpsi, is correlated with an increased survival of glioblastoma multiforme patients. Hum. Mol. Genet. 2002, 11:675-687.
55. Upton J.P., Valentijn A.J., Zhang L., Gilmore A.P. The N-terminal conformation of Bax regulates cell commitment to apoptosis. Cell Death Differ. 2007, 14:932-942.
56. Peyerl F.W., Dai S., Murphy G.A., Crawford F., White J., Marrack P., Kappler J.W. Elucidation of some Bax conformational changes through crystallization of an antibody-peptide complex. Cell Death Differ. 2007, 14:447-452.
57. Hsu Y.T., Youle R.J. Nonionic detergents induce dimerization among members of the Bcl-2 family. J. Biol. Chem. 1997, 272:13829-13834.
58. Xiao Y., Zhong Y., Greene W., Dong F., Zhong G. Chlamydia trachomatis infection inhibits both Bax and Bak activation induced by staurosporine. Infect. Immun. 2004, 72:5470-5474.
59. George N.M., Evans J.J., Luo X. A three-helix homo-oligomerization domain containing BH3 and BH1 is responsible for the apoptotic activity of Bax. Genes Dev. 2007, 21:1937-1948.
60. Dewson G., Kratina T., Sim H.W., Puthalakath H., Adams J.M., Colman P.M., Kluck R.M. To trigger apoptosis Bak exposes its BH3 domain and homo-dimerizes via BH3:groove interactions. Mol. Cell 2008, 30:369-380.
61. Gavathiotis E., Reyna D.E., Davis M.L., Bird G.H., Walensky L.D. BH3-triggered structural reorganization drives the activation of proapoptotic BAX. Mol. Cell 2010, 40:481-492.
62. Zhang Z., Zhu W., Lapolla S.M., Miao Y., Shao Y., Falcone M., Boreham D., McFarlane N., Ding J., Johnson A.E., Zhang X.C., Andrews D.W., Lin J. Bax forms an oligomer via separate, yet interdependent, surfaces. J. Biol. Chem. 2010, 285:17614-17627.
63. L, an inhibitor of programmed cell death. Nature 1996, 381:335-341.
64. Annis M.G., Soucie E.L., Dlugosz P.J., Cruz-Aguado J.A., Penn L.Z., Leber B., Andrews D.W. Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis. EMBO J. 2005, 24:2096-2103.
65. Lalier L., Cartron P.F., Juin P., Nedelkina S., Manon S., Bechinger B., Vallette F.M. Bax activation and mitochondrial insertion during apoptosis. Apoptosis 2007, 12:887-896.
66. Yethon J.A., Epand R.F., Leber B., Epand R.M., Andrews D.W. Interaction with a membrane surface triggers a reversible conformational change in Bax normally associated with induction of apoptosis. J. Biol. Chem. 2003, 278:48935-48941.
67. Antonsson B., Montessuit S., Sanchez B., Martinou J.C. Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells. J. Biol. Chem. 2001, 276:11615-11623.
68. Wei M.C., Lindsten T., Mootha V.K., Weiler S., Gross A., Ashiya M., Thompson C.B., Korsmeyer S.J. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev. 2000, 14:2060-2071.
69. Reed J.C. Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities. Cell Death Differ. 2006, 13:1378-1386.
70. Bleicken S., Classen M., Padmavathi P.V., Ishikawa T., Zeth K., Steinhoff H.J., Bordignon E. Molecular details of Bax activation, oligomerization, and membrane insertion. J. Biol. Chem. 2010, 285:6636-6647.
71. Oh K.J., Singh P., Lee K., Foss K., Lee S., Park M., Aluvila S., Kim R.S., Smyersky J., Walters D.E. Conformational changes in BAK, a pore-forming proapoptotic Bcl-2 family member, upon membrane insertion and direct evidence for the existence of BH3:BH3 contact interface in BAK homooligomers. J. Biol. Chem. 2010.
72. Jeong S.Y., Gaume B., Lee Y.J., Hsu Y.T., Ryu S.W., Yoon S.H., Youle R.J. Bcl-x(L) sequesters its C-terminal membrane anchor in soluble, cytosolic homodimers. EMBO J. 2004, 23:2146-2155.
73. O'Neill J.W., Manion M.K., Maguire B., Hockenbery D.M. BCL-XL dimerization by three-dimensional domain swapping. J. Mol. Biol. 2006, 356:367-381.
74. Willis S.N., Chen L., Dewson G., Wei A., Naik E., Fletcher J.I., Adams J.M., Huang D.C. Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev. 2005, 19:1294-1305.
75. Fletcher J.I., Meusburger S., Hawkins C.J., Riglar D.T., Lee E.F., Fairlie W.D., Huang D.C., Adams J.M. Apoptosis is triggered when prosurvival Bcl-2 proteins cannot restrain Bax. Proc. Natl Acad. Sci. USA 2008, 105:18081-18087.
76. Leber B., Lin J., Andrews D.W. Embedded together: the life and death consequences of interaction of the Bcl-2 family with membranes. Apoptosis 2007, 12:897-911.
77. Ruffolo S.C., Shore G.C. BCL-2 selectively interacts with the BID-induced open conformer of BAK, inhibiting BAK auto-oligomerization. J. Biol. Chem. 2003, 278:25039-25045.
78. Murphy K.M., Ranganathan V., Farnsworth M.L., Kavallaris M., Lock R.B. Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells. Cell Death Differ. 2000, 7:102-111.
79. Smits C., Czabotar P.E., Hinds M.G., Day C.L. Structural plasticity underpins promiscuous binding of the pro-survival protein A1 2008, Structure Accepted 8/2/08.
80. L regulates the membrane potential and volume homeostasis of mitochondria. Cell 1997, 91:627-637.
81. Nakagawa T., Shimizu S., Watanabe T., Yamaguchi O., Otsu K., Yamagata H., Inohara H., Kubo T., Tsujimoto Y. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 2005, 434:652-658.
82. Tsujimoto Y., Shimizu S. Role of the mitochondrial membrane permeability transition in cell death. Apoptosis 2007, 12:835-840.
83. Chenal A., Prongidi-Fix L., Perier A., Aisenbrey C., Vernier G., Lambotte S., Haertlein M., Dauvergne M.T., Fragneto G., Bechinger B., Gillet D., Forge V., Ferrand M. Deciphering membrane insertion of the diphtheria toxin T domain by specular neutron reflectometry and solid-state NMR spectroscopy. J. Mol. Biol. 2009, 391:872-883.
84. Tilley S.J., Saibil H.R. The mechanism of pore formation by bacterial toxins. Curr. Opin. Struct. Biol. 2006, 16:230-236.
85. Kagan B.L., Finkelstein A., Colombini M. Diphtheria toxin fragment forms large pores in phospholipid bilayer membranes. Proc. Natl Acad. Sci. USA 1981, 78:4950-4954.
86. Kim P.K., Annis M.G., Dlugosz P.J., Leber B., Andrews D.W. During apoptosis bcl-2 changes membrane topology at both the endoplasmic reticulum and mitochondria. Mol. Cell 2004, 14:523-529.
87. Schlesinger P.H., Gross A., Yin X.M., Yamamoto K., Saito M., Waksman G., Korsmeyer S.J. Comparison of the ion channel characteristics of proapoptotic BAX and antiapoptotic BCL-2. Proc. Natl Acad. Sci. USA 1997, 94:11357-11362.
88. Antonsson B., Conti F., Ciavatta A., Montessuit S., Lewis S., Martinou I., Bernasconi L., Bernard A., Mermod J.J., Mazzei G., Maundrell K., Gambale F., Sadoul R., Martinou J.C. Inhibition of Bax channel-forming activity by Bcl-2. Science 1997, 277:370-372.
89. Minn A.J., Velez P., Schendel S.L., Liang H., Muchmore S.W., Fesik S.W., Fill M., Thompson C.B. Bcl-x(L) forms an ion channel in synthetic lipid membranes. Nature 1997, 385:353-357.
90. Schendel S.L., Xie Z., Montal M.O., Matsuyama S., Montal M., Reed J.C. Channel formation by antiapoptotic protein Bcl-2. Proc. Natl Acad. Sci. USA 1997, 94:5113-5118.
91. Dejean L.M., Martinez-Caballero S., Guo L., Hughes C., Teijido O., Ducret T., Ichas F., Korsmeyer S.J., Antonsson B., Jonas E.A., Kinnally K.W. Oligomeric Bax is a component of the putative cytochrome c release channel MAC, mitochondrial apoptosis-induced channel. Mol. Biol. Cell 2005, 16:2424-2432.
92. Pavlov E.V., Priault M., Pietkiewicz D., Cheng E.H., Antonsson B., Manon S., Korsmeyer S.J., Mannella C.A., Kinnally K.W. A novel, high conductance channel of mitochondria linked to apoptosis in mammalian cells and Bax expression in yeast. J. Cell Biol. 2001, 155:725-732.
93. Kuwana T., Mackey M.R., Perkins G., Ellisman M.H., Latterich M., Schneiter R., Green D.R., Newmeyer D.D. Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 2002, 111:331-342.
94. Saito M., Korsmeyer S.J., Schlesinger P.H. BAX-dependent transport of cytochrome c reconstituted in pure liposomes. Nat. Cell Biol. 2000, 2:553-555.
95. Martinez-Caballero S., Dejean L.M., Kinnally M.S., Oh K.J., Mannella C.A., Kinnally K.W. Assembly of the mitochondrial apoptosis-induced channel. MAC J. Biol. Chem. 2009, 284:12235-12245.
96. Nechushtan A., Smith C.L., Lamensdorf I., Yoon S.H., Youle R.J. Bax and Bak coalesce into novel mitochondria-associated clusters during apoptosis. J. Cell Biol. 2001, 153:1265-1276.
97. Zhou L., Chang D.C. Dynamics and structure of the Bax-Bak complex responsible for releasing mitochondrial proteins during apoptosis. J. Cell Sci. 2008, 121:2186-2196.
98. Ross K., Rudel T., Kozjak-Pavlovic V. TOM-independent complex formation of Bax and Bak in mammalian mitochondria during TNFalpha-induced apoptosis. Cell Death Differ. 2009, 16:697-707.
99. Garcia-Saez A.J., Coraiola M., Serra M.D., Mingarro I., Muller P., Salgado J. Peptides corresponding to helices 5 and 6 of Bax can independently form large lipid pores. FEBS J. 2006, 273:971-981.
100. Lovell J.F., Billen L.P., Bindner S., Shamas-Din A., Fradin C., Leber B., Andrews D.W. Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax. Cell 2008, 135:1074-1084.
101. Yang L., Harroun T.A., Weiss T.M., Ding L., Huang H.W. Barrel-stave model or toroidal model? A case study on melittin pores. Biophys. J. 2001, 81:1475-1485.
102. He K., Ludtke S.J., Heller W.T., Huang H.W. Mechanism of alamethicin insertion into lipid bilayers. Biophys. J. 1996, 71:2669-2679.
103. Mueller M., Grauschopf U., Maier T., Glockshuber R., Ban N. The structure of a cytolytic alpha-helical toxin pore reveals its assembly mechanism. Nature 2009, 459:726-730.
104. Ludtke S.J., He K., Heller W.T., Harroun T.A., Yang L., Huang H.W. Membrane pores induced by magainin. Biochemistry 1996, 35:13723-13728.
105. Matsuzaki K., Sugishita K., Ishibe N., Ueha M., Nakata S., Miyajima K., Epand R.M. Relationship of membrane curvature to the formation of pores by magainin 2. Biochemistry 1998, 37:11856-11863.
106. Sobko A.A., Kotova E.A., Antonenko Y.N., Zakharov S.D., Cramer W.A. Lipid dependence of the channel properties of a colicin E1-lipid toroidal pore. J. Biol. Chem. 2006, 281:14408-14416.
107. Basanez G., Nechushtan A., Drozhinin O., Chanturiya A., Choe E., Tutt S., Wood K.A., Hsu Y., Zimmerberg J., Youle R.J. Bax, but not Bcl-xL, decreases the lifetime of planar phospholipid bilayer membranes at subnanomolar concentrations. Proc. Natl Acad. Sci. USA 1999, 96:5492-5497.
108. Basanez G., Sharpe J.C., Galanis J., Brandt T.B., Hardwick J.M., Zimmerberg J. Bax-type apoptotic proteins porate pure lipid bilayers through a mechanism sensitive to intrinsic monolayer curvature. J. Biol. Chem. 2002, 277:49360-49365.
109. Terrones O., Antonsson B., Yamaguchi H., Wang H.G., Liu J., Lee R.M., Herrmann A., Basanez G. Lipidic pore formation by the concerted action of proapoptotic BAX and tBID. J. Biol. Chem. 2004, 279:30081-30091.
110. Qian S., Wang W., Yang L., Huang H.W. Structure of transmembrane pore induced by Bax-derived peptide: evidence for lipidic pores. Proc. Natl Acad. Sci. USA 2008, 105:17379-17383.
111. Karbowski M., Lee Y.J., Gaume B., Jeong S.Y., Frank S., Nechushtan A., Santel A., Fuller M., Smith C.L., Youle R.J. Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis. J. Cell Biol. 2002, 159:931-938.